You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Mallinckrodt
Harvard Business School
Dow
McKesson

Last Updated: February 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MEXILETINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Mexiletine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000464 Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1987-04-01 To compare the efficacy of amiodarone to conventional anti-arrhythmic therapy in individuals who had survived one episode of out-of-hospital cardiac arrest.
NCT00000464 Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) Completed University of Washington Phase 3 1987-04-01 To compare the efficacy of amiodarone to conventional anti-arrhythmic therapy in individuals who had survived one episode of out-of-hospital cardiac arrest.
NCT00000518 Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1985-07-01 To determine whether electrophysiologic study (EPS) or Holter monitoring (HM) was the better method for selecting effective long-term antiarrhythmic drug therapy in patients with sustained ventricular tachycardia, ventricular fibrillation, or an episode of aborted sudden death.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Mexiletine Hydrochloride

Condition Name

Condition Name for Mexiletine Hydrochloride
Intervention Trials
Cardiovascular Diseases 2
Heart Diseases 2
Sporadic Amyotrophic Lateral Sclerosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Mexiletine Hydrochloride
Intervention Trials
Myotonia 4
Myotonic Disorders 4
Myotonic Dystrophy 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Mexiletine Hydrochloride

Trials by Country

Trials by Country for Mexiletine Hydrochloride
Location Trials
United States 70
Canada 4
United Kingdom 2
Denmark 2
Netherlands 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Mexiletine Hydrochloride
Location Trials
New York 7
Massachusetts 5
California 5
Pennsylvania 4
Texas 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Mexiletine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Mexiletine Hydrochloride
Clinical Trial Phase Trials
Phase 4 4
Phase 3 7
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Mexiletine Hydrochloride
Clinical Trial Phase Trials
Completed 17
Recruiting 4
Not yet recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mexiletine Hydrochloride

Sponsor Name

Sponsor Name for Mexiletine Hydrochloride
Sponsor Trials
Lupin Ltd. 3
University of Washington 3
University of Rochester 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Mexiletine Hydrochloride
Sponsor Trials
Other 25
NIH 6
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
Dow
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.